Skip to main content

Search

Reset all filters
760 Result(s)
Sort by

Landmark trial demonstrates Jardiance® (empagliflozin) is the first therapy to show statistically significant improvement in heart failure outcomes in adults with preserved ejection fraction

Landmark trial demonstrates Jardiance® (empagliflozin) is the first therapy to show statistically significant improvement in heart failure outcomes in adults with preserved ejection fraction

Landmark trial demonstrates Jardiance® (empagliflozin) is the first therapy to show statistically significant improvement in heart failure outcomes in adults with preserved ejection fraction
Confronting health disparities in clinical trials

Confronting health disparities in clinical trials

As a research-driven pharmaceutical company, one of our priorities is to ensure there’s more representation from underserved communities, particularly for clinical cancer trials.
Venu Thatikonda

Venu Thatikonda

An in-depth look into working life at Boehringer Ingelheim with Venu Thatikonda.
Ridgefield, CT | BI Facilities

Ridgefield, CT | BI Facilities

BI was established in Connecticut in 1971 and broke ground on September 1st, 1989 in Ridgefield. This site is home to the U.S. HQ of Boehringer Ingelheim
Biberach

Biberach

Click here to view our Biberach site, in Southern Germany, home to the largest research & development center within Boehringer Ingelheim’s global network.
Imprint

Imprint

Here you can access contact details and information about Boehringer Ingelheim
Kei Kato

Kei Kato

Kei Kato, Head of Purchasing in Japan, describes a career at Boehringer Ingelheim as intense and exciting.
Ridgefield Research and Innovation

Ridgefield Research and Innovation

Ridgefield, CT, USA is Boehringer Ingelheim's 3rd largest research sit, where scientists are tackling some of the most difficult challenges in healthcare.
Medicine & Regulatory Video

Medicine & Regulatory Video

Taimi Sahlin, a therapeutic specialist with Boehringer Ingelheim Canada describes her career as challenging and motivating.
Interdisciplinary approach to CKM care

Interdisciplinary approach to CKM care

Explore the global impact of Cardiovascular- Kidney- Metabolic (CKM) syndrome, and the need for an integrated approach to manage these interconnected conditions. Insights from experts at Boehringer Ingelheim and George Washington University.
Christina Schmitt

Christina Schmitt

Christina Schmitt loves that she can be creative every day as a biopharma management trainee at Boehringer Ingelheim.
Dirk Esser

Dirk Esser

Dirk Esser speaks about his 12 year career at Boehringer Ingelheim and the various growth opportunities.
About Us

About Us

Click here to discover more about Boehringer Ingelheim and our headquarters and largest U.S subsidiary in Connecticut.
Meeting the Challenge in Animal Health

Meeting the Challenge in Animal Health

Video showing how Boehringer Ingelheim Animal Health is driving collaboration and innovation to Meet the Challenge in Animal Health.
Marie Penzold

Marie Penzold

Marie Penzold talks about her career as a HR business partner in the Innovation unit here at Boehringer Ingelheim.
Dr. Hsing-Jung Chen-Engerer

Dr. Hsing-Jung Chen-Engerer

Dr. Hsing-Jung Chen-Engerer of Research & Development speaks about his fulfilling career with Boehringer Ingelheim.